Support our research against cancer

The Beljanski Foundation’s overall mission is to study and share knowledge of effective non-toxic natural answers that work both alone and in synergy with traditional western medicine to cure cancer and other chronic diseases the natural way.

The importance of scientific research

The World Health Organization predicts that the number of cancers will double by 2030, and more and more of us are hearing those terrible words: “You have cancer”. Cancer has grown into a billion dollar industry, but conventional cancer treatments still involve surgery, chemotherapy, and radiation therapy. Fortunately, there are natural molecules capable of selectively blocking the proliferation of cancer cells, without destroying healthy cells.

For research on these molecules to continue, we need your support …

The 2021 Foundation and research program

The new experiments are focused on melanoma, and more specifically, the potential beneficial effects of the yellow leaf Gingko extract for an anti-melanoma effect.

We need to emphasize that the effect is not killing the cancer cells. The yellow leaf Ginkgo extract is not especially toxic to cancer cells but has a very powerful anti-melanoma effect. We know from Mirko Beljanski’s work that the yellow leaf Ginkgo extract suppresses and inhibits the activity of a whole family of enzymes that are released by melanoma cancer cells. And these are specifically rnases. They are enzymes that chop up or process RNA into different fragments, each which may have a different activity.
These are powerful kinds of enzymes that are overexpressed and secreted by melanoma cancer cells. The ability of a Ginkgo extract to inhibit these is what we’re focused on because of one of these rnases, and there are at least 15 that are secreted.
Besides, we can see a broad effect of the Ginkgo extract against the activity of all these enzymes. But what we need to know is whether or not we are inhibiting a specific enzyme called angiogenesis.

Angiogenesis is one of these rnases that serves to stimulate the recruitment of new blood vessels to a tumor. It’s dastardly. When the tumor sends out the signal, which is an RNA, it’s called angiogenesis. But angiogenesis is the process of new blood supply being generated for the tumor.
In other words, instead of killing the cancer cell directly, we are starving it by preventing it to access the blood supply, it needs to grow and flourish in a nasty tumor.
We have to wait and do the experiment because if you starve it, it’ll still be there, we will be slowing the growth.
We don’t know if there may be a tumor shrinkage effect, we’d have to do the animal studies to show. The angiogenesis is a target of the Ginkgo extract inhibition.

We know that the Pao Pereira extract has this effect on the whole family of secreted rnases. But the next step is to determine specifically that inhibits angiogenin itself.
That’s the proposal for our next research to nail down.
There is anything out there that can inhibit angiogenesis without being toxic.

The Ginkgo extract can be taken in addition to the other compounds like Pao that you just mentioned, which have a direct article effect. It is a way to surround the cancer cells and from different angles and get them to surrender. There’s It is a tremendous opportunity for synergy there.
The power and revolving plant extracts are killing the cancer cells. But the Ginkgo extract could be there to prevent new blood supply that would enable the cancer to progress and grow.

Melanoma is on the rise. It’s a serious problem. I think we have all heard in the news that melanoma is not just a serious cancer, if it’s not caught early, it’s deadly. But there’s more and more of it for a variety of reasons, including environmental. But our interest also comes from history. And when Mirko Beljanski discovered the inhibitory effect of the Ginkgo extract on rnases, it was in the context of skin fibrosis, he discovered that irradiated skin, say for radiotherapy, the tissue that the radiation passes through is damaged and becomes fibrotic.
He found that those skin cells that are fibrotic are releasing these enzymes. He later went on to find that these enzymes were released by melanoma cells. So, the pathology is shared by skin fibrosis and skin cancer, specifically melanoma. And we have since come to learn that there are other types of cancers that release these rnases: the breast cancer, pancreatic cancer and leukemia, for example.
If all goes well, it could benefit to other kind of cancer cells.
Indeed, melanoma isn’t the only kind of cancer that needs new blood to thrive.We think it’s going to have ,if not complete, at least a broad applicability to different kinds of cancer cells.
We’ve worked in collaboration with Dr Chen from Kansas University over the years on quite a few projects, including pancreatic cancer, ovarian cancer, and the respective cancer stem cells. She is very interested in this angiogenin and RNAs inhibition project. And we’ve worked out a budget for this step, which is $16,500.

If this works out as we hope it’s a major breakthrough in cancer therapy good because we have a plant extract nontoxic that can interfere with one of the central strategies of these cancers, which is to enable growth with new blood supply.

Skin Cancer Research: Melanoma

Our skin cancer research is focused on melanoma—the most serious kind of skin cancer.

Two plant extracts– green tea extract blend (OnkoTea) and yellow leaf Ginkgo V and will be studied for their anti-melanoma activity.   And as skin is exposed, we will explore topical in addition to oral approach…

$6,410 of $16,000 raised

February 15th 2021

Launch of our research

Learn more
Skin Cancer Research Melanoma

Pao pereira extract: Suppression of Cytokine IL-6 in Hyperinflammation

Beljanski demonstrated that the Pao pereira extract suppresses cytokine IL-6 induced proliferation of brain cancer cells (glioblastoma). He showed that the extract significantly reduces the amount of IL-6 in the cancer cells. IL-6 is also induced in some viral infections and in the case of COVID-19, it is one of the prominent cytokines in the hyperinflammation response that is associated with severe viral infections.

$1,051 of $15,000 raised

April 15th 2021

Launch of our research

Learn more